Using advanced imaging to improve treatment for pulmonary fibrosis
The role of quantitative CT and radiomic biomarkers for precision medicine in pulmonary fibrosis
This study is looking at how special CT scans and imaging features can help doctors better understand and treat patients with idiopathic pulmonary fibrosis (IPF) by predicting how the disease will progress and how well treatments might work.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11019829 on NIH RePORTER |
What this research studies
This research investigates how quantitative CT scans and radiomic biomarkers can enhance precision medicine for patients with idiopathic pulmonary fibrosis (IPF). By analyzing high-dimensional imaging data, the study aims to identify specific characteristics of the disease that can help predict progression and response to treatment. The research builds on previous work that has generated novel molecular markers and seeks to integrate these findings with imaging data to improve clinical decision-making. Patients participating in this research may undergo additional CT scans to evaluate their disease more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis who are undergoing treatment.
Not a fit: Patients with other forms of lung disease or those not diagnosed with idiopathic pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment strategies for patients with pulmonary fibrosis, potentially improving their outcomes.
How similar studies have performed: Previous research has shown promise in using imaging techniques and biomarkers for similar conditions, indicating that this approach could be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Noth, Imre — University of Virginia
- Study coordinator: Noth, Imre
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.